Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_assertion description "[Because CYP2D6 is known to be an important enzyme responsible for the generation of the potent tamoxifen metabolite, 'endoxifen', lots of studies reported that genetic variation which reduced its enzyme activity were associated with poor clinical outcome of breast cancer patients treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_assertion evidence source_evidence_literature NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_assertion SIO_000772 25712191 NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_assertion wasDerivedFrom befree-2016 NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_assertion wasGeneratedBy ECO_0000203 NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.
- befree-2016 importedOn "2016-02-19" NP1266043.RA_TubV-niqAh6N8QpUF5t7G6jKsNyQTHJSoFj1huBkMg130_provenance.